SRF shares climb 4% on Axis Capital upgrade despite target cut

Axis Capital said the company’s chemical business offers healthy medium-term growth potential and expects a 23% CAGR in this segment over FY25 to FY28.

Leave a Reply

Your email address will not be published. Required fields are marked *